Pulmonary fibrosis is a chronic progressive interstitial lung disease induced by multiple factors such as environmental exposure, infections. Its core pathological features are abnormal extracellular matrix deposition and myofibroblast over-activation. The efficacy of currently available therapeutic agents is limited, as they lack sufficient targeting capacity and are unable to reverse the progression of fibrosis. In recent years, pluripotent mesenchymal stem cells(MSCs) and their secreted extracellular vesicles(especially exosomes) have shown breakthrough potential in the treatment of pulmonary fibrosis due to their unique tissue repair and immunomodulatory functions. This article systematically reviewed the multidimensional antifibrotic mechanisms of MSCs and their extracellular vesicles(exosomes), deeply explored the engineered modification strategies(such as gene modification, novel vectors and delivery systems, and combined interventions) in enhancing therapeutic efficacy, and analyzed the challenges of translating from basic research to the clinic,in order to provide theoretical basis for the research of new anti-fibrosis drugs and the clinical application of MSCs.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |